ID   PAPS1_HUMAN             Reviewed;         624 AA.
AC   O43252; O43841; O75332; Q6IAX6; Q96FB1; Q96TF4; Q9P1P9; Q9UE98;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 2.
DT   12-APR-2017, entry version 180.
DE   RecName: Full=Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1;
DE            Short=PAPS synthase 1;
DE            Short=PAPSS 1;
DE   AltName: Full=Sulfurylase kinase 1;
DE            Short=SK 1;
DE            Short=SK1;
DE   Includes:
DE     RecName: Full=Sulfate adenylyltransferase;
DE              EC=2.7.7.4 {ECO:0000269|PubMed:14747722, ECO:0000269|PubMed:9576487, ECO:0000269|PubMed:9648242, ECO:0000269|PubMed:9668121};
DE     AltName: Full=ATP-sulfurylase;
DE     AltName: Full=Sulfate adenylate transferase;
DE              Short=SAT;
DE   Includes:
DE     RecName: Full=Adenylyl-sulfate kinase;
DE              EC=2.7.1.25 {ECO:0000269|PubMed:14747722, ECO:0000269|PubMed:17276460, ECO:0000269|PubMed:17540769, ECO:0000269|PubMed:9576487, ECO:0000269|PubMed:9648242, ECO:0000269|PubMed:9668121};
DE     AltName: Full=3'-phosphoadenosine-5'-phosphosulfate synthase;
DE     AltName: Full=APS kinase;
DE     AltName: Full=Adenosine-5'-phosphosulfate 3'-phosphotransferase;
DE     AltName: Full=Adenylylsulfate 3'-phosphotransferase;
GN   Name=PAPSS1; Synonyms=ATPSK1, PAPSS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY,
RP   ENZYME REGULATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Tonsil;
RX   PubMed=9576487;
RA   Girard J.-P., Baekkevold E.S., Amalric F.;
RT   "Sulfation in high endothelial venules: cloning and expression of the
RT   human PAPS synthetase.";
RL   FASEB J. 12:603-612(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   PATHWAY, AND VARIANTS PHE-270 AND LEU-587.
RC   TISSUE=Fetal brain;
RX   PubMed=9668121; DOI=10.1074/jbc.273.30.19311;
RA   Venkatachalam K.V., Akita H., Strott C.A.;
RT   "Molecular cloning, expression, and characterization of human
RT   bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase and its
RT   functional domains.";
RL   J. Biol. Chem. 273:19311-19320(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RC   TISSUE=Brain;
RX   PubMed=9648242; DOI=10.1271/bbb.62.1037;
RA   Yanagisawa K., Sakakibara Y., Suiko M., Takami Y., Nakayama T.,
RA   Nakajima H., Takayanagi K., Natori Y., Liu M.-C.;
RT   "cDNA cloning, expression, and characterization of the human
RT   bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate kinase
RT   enzyme.";
RL   Biosci. Biotechnol. Biochem. 62:1037-1040(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LEU-587.
RA   Deyrup A.T.;
RT   "Human ATP sulfurylase/APS kinase.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANT LEU-587.
RC   TISSUE=Brain;
RX   PubMed=10679223; DOI=10.1006/bbrc.2000.2123;
RA   Xu Z.-H., Otterness D.M., Freimuth R.R., Carlini E.J., Wood T.C.,
RA   Mitchell S., Moon E., Kim U.-J., Xu J.-P., Siciliano M.J.,
RA   Weinshilboum R.M.;
RT   "Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and
RT   PAPSS2: gene cloning, characterization and chromosomal localization.";
RL   Biochem. Biophys. Res. Commun. 268:437-444(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Trachea {ECO:0000312|EMBL:BAF85463.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   MUTAGENESIS OF HIS-425; ASN-426; GLY-427 AND HIS-428.
RX   PubMed=9915785; DOI=10.1074/jbc.274.5.2601;
RA   Venkatachalam K.V., Fuda H., Koonin E.V., Strott C.A.;
RT   "Site-selected mutagenesis of a conserved nucleotide binding HXGH
RT   motif located in the ATP sulfurylase domain of human bifunctional 3'-
RT   phosphoadenosine 5'-phosphosulfate synthase.";
RL   J. Biol. Chem. 274:2601-2604(1999).
RN   [11]
RP   CRYSTALLIZATION, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, AND PATHWAY.
RX   PubMed=14747722; DOI=10.1107/S0907444903027628;
RA   Harjes S., Scheidig A., Bayer P.;
RT   "Expression, purification and crystallization of human 3'-
RT   phosphoadenosine-5'-phosphosulfate synthetase 1.";
RL   Acta Crystallogr. D 60:350-352(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEXES WITH ATP ANALOGS,
RP   SUBUNIT, AND DOMAIN.
RX   PubMed=15755455; DOI=10.1016/j.jmb.2005.01.005;
RA   Harjes S., Bayer P., Scheidig A.J.;
RT   "The crystal structure of human PAPS synthetase 1 reveals asymmetry in
RT   substrate binding.";
RL   J. Mol. Biol. 347:623-635(2005).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 51-226 IN COMPLEXES WITH ATP
RP   AND 3'-PHOSPHO-5'-ADENYLYL SULFATE ANALOGS, CATALYTIC ACTIVITY,
RP   SUBUNIT, MUTAGENESIS OF ARG-37 AND ARG-40, DOMAIN, AND ENZYME
RP   REGULATION.
RX   PubMed=17540769; DOI=10.1074/jbc.M701713200;
RA   Sekulic N., Konrad M., Lavie A.;
RT   "Structural mechanism for substrate inhibition of the adenosine 5'-
RT   phosphosulfate kinase domain of human 3'-phosphoadenosine 5'-
RT   phosphosulfate synthetase 1 and its ramifications for enzyme
RT   regulation.";
RL   J. Biol. Chem. 282:22112-22121(2007).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 25-227 IN COMPLEXES WITH
RP   3'-PHOSPHO-5'-ADENYLYL SULFATE AND ADENOSINE-5'-PHOSPHOSULFATE,
RP   CATALYTIC ACTIVITY, AND DOMAIN.
RX   PubMed=17276460; DOI=10.1016/j.jmb.2007.01.025;
RA   Sekulic N., Dietrich K., Paarmann I., Ort S., Konrad M., Lavie A.;
RT   "Elucidation of the active conformation of the APS-kinase domain of
RT   human PAPS synthetase 1.";
RL   J. Mol. Biol. 367:488-500(2007).
CC   -!- FUNCTION: Bifunctional enzyme with both ATP sulfurylase and APS
CC       kinase activity, which mediates two steps in the sulfate
CC       activation pathway. The first step is the transfer of a sulfate
CC       group to ATP to yield adenosine 5'-phosphosulfate (APS), and the
CC       second step is the transfer of a phosphate group from ATP to APS
CC       yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor
CC       used by sulfotransferase). In mammals, PAPS is the sole source of
CC       sulfate; APS appears to be only an intermediate in the sulfate-
CC       activation pathway (PubMed:9576487, PubMed:9668121,
CC       PubMed:9648242, PubMed:14747722). Required for normal biosynthesis
CC       of sulfated L-selectin ligands in endothelial cells
CC       (PubMed:9576487). {ECO:0000269|PubMed:14747722,
CC       ECO:0000269|PubMed:9576487, ECO:0000269|PubMed:9648242,
CC       ECO:0000269|PubMed:9668121}.
CC   -!- CATALYTIC ACTIVITY: ATP + sulfate = diphosphate + adenylyl
CC       sulfate. {ECO:0000269|PubMed:14747722, ECO:0000269|PubMed:9576487,
CC       ECO:0000269|PubMed:9648242, ECO:0000269|PubMed:9668121}.
CC   -!- CATALYTIC ACTIVITY: ATP + adenylyl sulfate = ADP + 3'-
CC       phosphoadenylyl sulfate. {ECO:0000269|PubMed:14747722,
CC       ECO:0000269|PubMed:17276460, ECO:0000269|PubMed:17540769,
CC       ECO:0000269|PubMed:9576487, ECO:0000269|PubMed:9648242,
CC       ECO:0000269|PubMed:9668121}.
CC   -!- ENZYME REGULATION: Inhibited by chlorate (PubMed:9576487). The
CC       kinase activity is subject to inhibition by the substrate adenylyl
CC       sulfate (PubMed:17540769). {ECO:0000269|PubMed:17540769,
CC       ECO:0000269|PubMed:9576487}.
CC   -!- PATHWAY: Sulfur metabolism; sulfate assimilation.
CC       {ECO:0000269|PubMed:14747722, ECO:0000269|PubMed:9576487,
CC       ECO:0000269|PubMed:9648242, ECO:0000269|PubMed:9668121}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:14747722,
CC       ECO:0000269|PubMed:15755455, ECO:0000269|PubMed:17540769}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis, pancreas, kidney, thymus,
CC       prostate, ovary, small intestine, colon, leukocytes and liver.
CC       Also expressed in high endothelial venules (HEV) cells and in
CC       cartilage. {ECO:0000269|PubMed:9576487}.
CC   -!- DOMAIN: The N-terminal first 50 residues are required for
CC       inhibition by the substrate adenylyl sulfate.
CC       {ECO:0000269|PubMed:17540769}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the APS kinase
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the sulfate
CC       adenylyltransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y10387; CAA71413.1; -; mRNA.
DR   EMBL; U53447; AAC39894.1; -; Genomic_DNA.
DR   EMBL; AF033026; AAC28429.1; -; mRNA.
DR   EMBL; AF016496; AAD09325.1; -; mRNA.
DR   EMBL; AF105227; AAF40236.1; -; mRNA.
DR   EMBL; AF097721; AAF40235.1; -; Genomic_DNA.
DR   EMBL; AF097710; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097711; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097712; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097713; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097714; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097715; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097716; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097717; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097718; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097719; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AF097720; AAF40235.1; JOINED; Genomic_DNA.
DR   EMBL; AK292774; BAF85463.1; -; mRNA.
DR   EMBL; CR457028; CAG33309.1; -; mRNA.
DR   EMBL; CH471057; EAX06210.1; -; Genomic_DNA.
DR   EMBL; BC011392; AAH11392.1; -; mRNA.
DR   EMBL; BC050627; AAH50627.1; -; mRNA.
DR   CCDS; CCDS3676.1; -.
DR   PIR; JW0087; JW0087.
DR   RefSeq; NP_005434.4; NM_005443.4.
DR   RefSeq; XP_011530702.1; XM_011532400.1.
DR   RefSeq; XP_011530703.1; XM_011532401.1.
DR   UniGene; Hs.368610; -.
DR   PDB; 1X6V; X-ray; 1.75 A; A/B=1-624.
DR   PDB; 1XJQ; X-ray; 2.06 A; A/B=1-624.
DR   PDB; 1XNJ; X-ray; 1.98 A; A/B=1-624.
DR   PDB; 2OFW; X-ray; 2.05 A; A/B/C/D/E/F/G/H=24-225.
DR   PDB; 2OFX; X-ray; 1.90 A; A/B=25-227.
DR   PDB; 2PEY; X-ray; 1.88 A; A/B=51-226.
DR   PDB; 2PEZ; X-ray; 1.40 A; A/B=51-226.
DR   PDB; 2QJF; X-ray; 2.20 A; A/B=220-624.
DR   PDBsum; 1X6V; -.
DR   PDBsum; 1XJQ; -.
DR   PDBsum; 1XNJ; -.
DR   PDBsum; 2OFW; -.
DR   PDBsum; 2OFX; -.
DR   PDBsum; 2PEY; -.
DR   PDBsum; 2PEZ; -.
DR   PDBsum; 2QJF; -.
DR   ProteinModelPortal; O43252; -.
DR   SMR; O43252; -.
DR   BioGrid; 114522; 45.
DR   IntAct; O43252; 12.
DR   MINT; MINT-1372331; -.
DR   STRING; 9606.ENSP00000265174; -.
DR   DrugBank; DB03708; Adenosine-5'-Phosphosulfate.
DR   DrugBank; DB04077; Glycerol.
DR   iPTMnet; O43252; -.
DR   PhosphoSitePlus; O43252; -.
DR   BioMuta; PAPSS1; -.
DR   EPD; O43252; -.
DR   PaxDb; O43252; -.
DR   PeptideAtlas; O43252; -.
DR   PRIDE; O43252; -.
DR   DNASU; 9061; -.
DR   Ensembl; ENST00000265174; ENSP00000265174; ENSG00000138801.
DR   GeneID; 9061; -.
DR   KEGG; hsa:9061; -.
DR   UCSC; uc003hyk.4; human.
DR   CTD; 9061; -.
DR   DisGeNET; 9061; -.
DR   GeneCards; PAPSS1; -.
DR   HGNC; HGNC:8603; PAPSS1.
DR   HPA; HPA049781; -.
DR   MIM; 603262; gene.
DR   neXtProt; NX_O43252; -.
DR   OpenTargets; ENSG00000138801; -.
DR   PharmGKB; PA384; -.
DR   eggNOG; KOG0635; Eukaryota.
DR   eggNOG; KOG4238; Eukaryota.
DR   eggNOG; COG0529; LUCA.
DR   eggNOG; COG2046; LUCA.
DR   GeneTree; ENSGT00390000009613; -.
DR   HOVERGEN; HBG053503; -.
DR   KO; K13811; -.
DR   OMA; RRPEFYY; -.
DR   OrthoDB; EOG091G07ZR; -.
DR   PhylomeDB; O43252; -.
DR   TreeFam; TF313143; -.
DR   BioCyc; MetaCyc:HS06566-MONOMER; -.
DR   BRENDA; 2.7.1.25; 2681.
DR   BRENDA; 2.7.7.4; 2681.
DR   Reactome; R-HSA-174362; Transport and synthesis of PAPS.
DR   Reactome; R-HSA-2408550; Metabolism of ingested H2SeO4 and H2SeO3 into H2Se.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   SABIO-RK; O43252; -.
DR   UniPathway; UPA00097; -.
DR   ChiTaRS; PAPSS1; human.
DR   EvolutionaryTrace; O43252; -.
DR   GeneWiki; PAPSS1; -.
DR   GenomeRNAi; 9061; -.
DR   PRO; PR:O43252; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000138801; -.
DR   CleanEx; HS_PAPSS1; -.
DR   ExpressionAtlas; O43252; baseline and differential.
DR   Genevisible; O43252; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004020; F:adenylylsulfate kinase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016779; F:nucleotidyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004781; F:sulfate adenylyltransferase (ATP) activity; IDA:UniProtKB.
DR   GO; GO:0050428; P:3'-phosphoadenosine 5'-phosphosulfate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   GO; GO:0000103; P:sulfate assimilation; IDA:UniProtKB.
DR   CDD; cd02027; APSK; 1.
DR   CDD; cd00517; ATPS; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   HAMAP; MF_00065; Adenylyl_sulf_kinase; 1.
DR   InterPro; IPR002891; APS_kinase.
DR   InterPro; IPR025980; ATP-Sase_PUA-like_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR015947; PUA-like_domain.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR024951; Sulfurylase_cat_dom.
DR   InterPro; IPR002650; Sulphate_adenylyltransferase.
DR   Pfam; PF01747; ATP-sulfurylase; 1.
DR   Pfam; PF14306; PUA_2; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF88697; SSF88697; 1.
DR   TIGRFAMs; TIGR00455; apsK; 1.
DR   TIGRFAMs; TIGR00339; sopT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Multifunctional enzyme; Nucleotide-binding; Nucleotidyltransferase;
KW   Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    624       Bifunctional 3'-phosphoadenosine 5'-
FT                                phosphosulfate synthase 1.
FT                                /FTId=PRO_0000105959.
FT   NP_BIND      62     67       ATP 1. {ECO:0000244|PDB:1X6V,
FT                                ECO:0000244|PDB:1XJQ,
FT                                ECO:0000244|PDB:1XNJ,
FT                                ECO:0000244|PDB:2OFX,
FT                                ECO:0000244|PDB:2PEY,
FT                                ECO:0000244|PDB:2PEZ,
FT                                ECO:0000269|PubMed:15755455,
FT                                ECO:0000269|PubMed:17276460,
FT                                ECO:0000269|PubMed:17540769}.
FT   NP_BIND     419    422       ATP 2. {ECO:0000244|PDB:1XJQ,
FT                                ECO:0000244|PDB:1XNJ,
FT                                ECO:0000244|PDB:2QJF,
FT                                ECO:0000269|PubMed:15755455}.
FT   NP_BIND     521    525       ATP 2. {ECO:0000244|PDB:1XJQ,
FT                                ECO:0000244|PDB:1XNJ,
FT                                ECO:0000244|PDB:2QJF,
FT                                ECO:0000269|PubMed:15755455}.
FT   REGION        1    225       Adenylyl-sulfate kinase.
FT                                {ECO:0000305|PubMed:15755455,
FT                                ECO:0000305|PubMed:17276460,
FT                                ECO:0000305|PubMed:17540769}.
FT   REGION       89     92       Adenylyl sulfate binding.
FT                                {ECO:0000244|PDB:2OFX,
FT                                ECO:0000305|PubMed:17276460}.
FT   REGION      106    109       Adenylyl sulfate binding.
FT                                {ECO:0000244|PDB:2OFX,
FT                                ECO:0000244|PDB:2PEZ,
FT                                ECO:0000305|PubMed:17276460,
FT                                ECO:0000305|PubMed:17540769}.
FT   REGION      132    133       Adenylyl sulfate binding.
FT                                {ECO:0000244|PDB:2OFX,
FT                                ECO:0000244|PDB:2PEZ,
FT                                ECO:0000305|PubMed:17276460,
FT                                ECO:0000305|PubMed:17540769}.
FT   REGION      184    185       Adenylyl sulfate binding.
FT                                {ECO:0000244|PDB:2OFX,
FT                                ECO:0000244|PDB:2PEZ,
FT                                ECO:0000305|PubMed:17276460,
FT                                ECO:0000305|PubMed:17540769}.
FT   REGION      234    624       Sulfate adenylyltransferase.
FT                                {ECO:0000305|PubMed:15755455}.
FT   BINDING     101    101       Adenylyl sulfate. {ECO:0000244|PDB:2OFX,
FT                                ECO:0000305|PubMed:17276460}.
FT   BINDING     171    171       Adenylyl sulfate. {ECO:0000244|PDB:2OFX,
FT                                ECO:0000305|PubMed:17276460}.
FT   BINDING     207    207       ATP 1; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:1X6V,
FT                                ECO:0000244|PDB:1XJQ,
FT                                ECO:0000244|PDB:1XNJ,
FT                                ECO:0000244|PDB:2OFW,
FT                                ECO:0000244|PDB:2OFX,
FT                                ECO:0000244|PDB:2PEY,
FT                                ECO:0000244|PDB:2PEZ,
FT                                ECO:0000269|PubMed:15755455,
FT                                ECO:0000269|PubMed:17276460,
FT                                ECO:0000269|PubMed:17540769}.
FT   BINDING     212    212       ATP 1. {ECO:0000244|PDB:2OFX,
FT                                ECO:0000269|PubMed:17276460}.
FT   BINDING     563    563       ATP 2; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000244|PDB:1XJQ,
FT                                ECO:0000244|PDB:1XNJ,
FT                                ECO:0000244|PDB:2QJF,
FT                                ECO:0000269|PubMed:15755455}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22223895}.
FT   MOD_RES      12     12       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q60967}.
FT   VARIANT     270    270       L -> F (in dbSNP:rs1127008).
FT                                {ECO:0000269|PubMed:9668121}.
FT                                /FTId=VAR_014065.
FT   VARIANT     587    587       S -> L (in dbSNP:rs1127014).
FT                                {ECO:0000269|PubMed:10679223,
FT                                ECO:0000269|PubMed:9668121,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_014064.
FT   MUTAGEN      37     37       R->A: Abolishes inhibition by the
FT                                substrate adenylyl sulfate.
FT                                {ECO:0000269|PubMed:17540769}.
FT   MUTAGEN      40     40       R->A: Abolishes inhibition by the
FT                                substrate adenylyl sulfate.
FT                                {ECO:0000269|PubMed:17540769}.
FT   MUTAGEN     425    425       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:9915785}.
FT   MUTAGEN     426    426       N->K: Increased activity.
FT                                {ECO:0000269|PubMed:9915785}.
FT   MUTAGEN     427    428       GH->AA: Loss of activity.
FT   MUTAGEN     427    427       G->A: 30% decrease in activity.
FT                                {ECO:0000269|PubMed:9915785}.
FT   MUTAGEN     428    428       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:9915785}.
FT   CONFLICT    456    456       G -> A (in Ref. 1; CAA71413).
FT                                {ECO:0000305}.
FT   CONFLICT    456    456       Missing (in Ref. 2; AAC39894).
FT                                {ECO:0000305}.
FT   CONFLICT    519    520       IV -> MC (in Ref. 4; AAD09325).
FT                                {ECO:0000305}.
FT   HELIX        37     43       {ECO:0000244|PDB:1X6V}.
FT   STRAND       44     49       {ECO:0000244|PDB:1X6V}.
FT   STRAND       53     58       {ECO:0000244|PDB:2PEZ}.
FT   HELIX        65     78       {ECO:0000244|PDB:2PEZ}.
FT   STRAND       83     87       {ECO:0000244|PDB:2PEZ}.
FT   HELIX        88     91       {ECO:0000244|PDB:2PEZ}.
FT   TURN         92     98       {ECO:0000244|PDB:2PEZ}.
FT   HELIX       103    122       {ECO:0000244|PDB:2PEZ}.
FT   STRAND      126    130       {ECO:0000244|PDB:2PEZ}.
FT   HELIX       136    148       {ECO:0000244|PDB:2PEZ}.
FT   STRAND      153    159       {ECO:0000244|PDB:2PEZ}.
FT   HELIX       162    168       {ECO:0000244|PDB:2PEZ}.
FT   HELIX       173    178       {ECO:0000244|PDB:2PEZ}.
FT   STRAND      181    184       {ECO:0000244|PDB:2OFX}.
FT   TURN        186    188       {ECO:0000244|PDB:2PEZ}.
FT   STRAND      199    203       {ECO:0000244|PDB:2PEZ}.
FT   TURN        204    206       {ECO:0000244|PDB:2PEZ}.
FT   HELIX       209    222       {ECO:0000244|PDB:2PEZ}.
FT   HELIX       241    243       {ECO:0000244|PDB:1X6V}.
FT   HELIX       244    252       {ECO:0000244|PDB:1X6V}.
FT   STRAND      256    258       {ECO:0000244|PDB:1X6V}.
FT   HELIX       261    271       {ECO:0000244|PDB:1X6V}.
FT   TURN        272    277       {ECO:0000244|PDB:1X6V}.
FT   HELIX       284    293       {ECO:0000244|PDB:1X6V}.
FT   STRAND      294    296       {ECO:0000244|PDB:1X6V}.
FT   STRAND      310    312       {ECO:0000244|PDB:1X6V}.
FT   HELIX       314    320       {ECO:0000244|PDB:1X6V}.
FT   STRAND      324    330       {ECO:0000244|PDB:1X6V}.
FT   STRAND      333    345       {ECO:0000244|PDB:1X6V}.
FT   HELIX       348    356       {ECO:0000244|PDB:1X6V}.
FT   HELIX       364    371       {ECO:0000244|PDB:1X6V}.
FT   STRAND      374    383       {ECO:0000244|PDB:1X6V}.
FT   HELIX       394    396       {ECO:0000244|PDB:1X6V}.
FT   HELIX       400    409       {ECO:0000244|PDB:1X6V}.
FT   STRAND      413    422       {ECO:0000244|PDB:1X6V}.
FT   HELIX       426    442       {ECO:0000244|PDB:1X6V}.
FT   STRAND      445    454       {ECO:0000244|PDB:1X6V}.
FT   HELIX       465    477       {ECO:0000244|PDB:1X6V}.
FT   HELIX       483    485       {ECO:0000244|PDB:1X6V}.
FT   STRAND      486    488       {ECO:0000244|PDB:1X6V}.
FT   HELIX       499    512       {ECO:0000244|PDB:1X6V}.
FT   STRAND      516    520       {ECO:0000244|PDB:1X6V}.
FT   TURN        530    532       {ECO:0000244|PDB:1X6V}.
FT   STRAND      534    537       {ECO:0000244|PDB:1X6V}.
FT   HELIX       541    548       {ECO:0000244|PDB:1X6V}.
FT   STRAND      556    559       {ECO:0000244|PDB:1X6V}.
FT   STRAND      563    566       {ECO:0000244|PDB:1X6V}.
FT   TURN        567    570       {ECO:0000244|PDB:1X6V}.
FT   STRAND      571    574       {ECO:0000244|PDB:1X6V}.
FT   HELIX       580    582       {ECO:0000244|PDB:1X6V}.
FT   HELIX       588    596       {ECO:0000244|PDB:1X6V}.
FT   HELIX       608    621       {ECO:0000244|PDB:1X6V}.
SQ   SEQUENCE   624 AA;  70833 MW;  A3DC9B943E68CDD6 CRC64;
     MEIPGSLCKK VKLSNNAQNW GMQRATNVTY QAHHVSRNKR GQVVGTRGGF RGCTVWLTGL
     SGAGKTTVSM ALEEYLVCHG IPCYTLDGDN IRQGLNKNLG FSPEDREENV RRIAEVAKLF
     ADAGLVCITS FISPYTQDRN NARQIHEGAS LPFFEVFVDA PLHVCEQRDV KGLYKKARAG
     EIKGFTGIDS EYEKPEAPEL VLKTDSCDVN DCVQQVVELL QERDIVPVDA SYEVKELYVP
     ENKLHLAKTD AETLPALKIN KVDMQWVQVL AEGWATPLNG FMREREYLQC LHFDCLLDGG
     VINLSVPIVL TATHEDKERL DGCTAFALMY EGRRVAILRN PEFFEHRKEE RCARQWGTTC
     KNHPYIKMVM EQGDWLIGGD LQVLDRVYWN DGLDQYRLTP TELKQKFKDM NADAVFAFQL
     RNPVHNGHAL LMQDTHKQLL ERGYRRPVLL LHPLGGWTKD DDVPLMWRMK QHAAVLEEGV
     LNPETTVVAI FPSPMMYAGP TEVQWHCRAR MVAGANFYIV GRDPAGMPHP ETGKDLYEPS
     HGAKVLTMAP GLITLEIVPF RVAAYNKKKK RMDYYDSEHH EDFEFISGTR MRKLAREGQK
     PPEGFMAPKA WTVLTEYYKS LEKA
//
